CADATRUS Trademark

Trademark Overview


On Tuesday, June 17, 2014, a trademark application was filed for CADATRUS with the United States Patent and Trademark Office. The USPTO has given the CADATRUS trademark a serial number of 86312110. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2016. This trademark is owned by Glaxo Group Limited. The CADATRUS trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, meta...
cadatrus

General Information


Serial Number86312110
Word MarkCADATRUS
Filing DateTuesday, June 17, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 28, 2014

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 25, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, July 25, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 25, 2016ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 15, 2015EXTENSION 2 GRANTED
Wednesday, November 18, 2015EXTENSION 2 FILED
Friday, December 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 18, 2015TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 1, 2015EXTENSION 1 GRANTED
Monday, June 1, 2015EXTENSION 1 FILED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Tuesday, December 23, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 28, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 28, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 8, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 25, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 24, 2014ASSIGNED TO EXAMINER
Wednesday, June 25, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 20, 2014NEW APPLICATION ENTERED IN TRAM